Technology | 2009.12.14
Pathway Medical Technologies Receives CE Mark for the Jetstream G2 NXT
KIRKLAND, Wash.--(BUSINESS WIRE)--Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), today announced that it received the CE Mark approval for its Jetstream G2TM NXT System, the company’s peripheral atherectomy catheter for use in the treatment of PAD. The CE Mark approval will allow the company to place the Jetstream G2 NXT on the market in all European Union countries, as well as other countries that accept this certificatio
For more information, please visit
http://www.businesswire.com/news/home/20091214005222/en
